Sept 4 (Reuters) -
* AMP GERMAN CANNABIS GROUP COMMENCE TRADING ON THE CSE AND ANNOUNCES INVESTMENT POLICY FOCUSED ON THE EUROPEAN MEDICAL CANNABIS INDUSTRY
* COMPANY'S COMMON SHARES WERE DELISTED FROM TSX VENTURE EXCHANGE AT CLOSE OF MARKET ON SEPTEMBER 3, 2019
* IT HAS UPDATED INVESTMENT POLICY TO ENHANCE SHAREHOLDER VALUE FROM INVESTMENTS IN EUROPEAN MEDICAL CANNABIS INDUSTRY
* AMP GERMAN CANNABIS- NEW INVESTMENTS WILL FOCUS ON SUPPLYING GERMANY WITH MEDICAL CANNABIS
* AMP GERMAN CANNABIS- AMP SWITZERLAND PLANS TO INVEST IN THE SWISS CANNABIS MARKET
* AMP GERMAN CANNABIS- AMP'S LEAD INVESTMENT, AMP GERMANY, PLANS TO BECOME A SIGNIFICANT IMPORTER OF MEDICAL CANNABIS TO GERMANY FROM CANADA
* AMP GERMAN CANNABIS- LIQUIDATING INVESTMENT PORTFOLIO UNDER ITS FORMER INVESTMENT POLICY AND INVESTING PROCEEDS IN THE EUROPEAN MEDIAL CANNABIS INDUSTRY